Alma Aurora Ramirez-Hernandez
Overview
Explore the profile of Alma Aurora Ramirez-Hernandez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos-Alvarez J, Velazquez-Enriquez J, Reyes-Jimenez E, Ramirez-Hernandez A, Iniguez-Palomares R, Rodriguez-Beas C, et al.
Mol Biol Rep
. 2024 Nov;
51(1):1166.
PMID: 39560703
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and highly fatal disease characterized by excessive accumulation of extracellular matrix (ECM), foci of myofibroblasts, and a usual pattern of interstitial pneumonia....
2.
Velazquez-Enriquez J, Santos-Alvarez J, Ramirez-Hernandez A, Reyes-Jimenez E, Perez-Campos Mayoral L, de Los Angeles Romero-Tlalolini M, et al.
Biochem Biophys Res Commun
. 2024 Sep;
734:150672.
PMID: 39260206
Aims: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung condition, the cause of which remains unknown and for which no effective therapeutic treatment is currently available. Chlorogenic acid...
3.
Lopez-Martinez A, Santos-Alvarez J, Velazquez-Enriquez J, Ramirez-Hernandez A, Vasquez-Garzon V, Baltierrez-Hoyos R
Noncoding RNA
. 2024 Apr;
10(2).
PMID: 38668384
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease marked by abnormal accumulation of extracellular matrix (ECM) due to dysregulated expression of various RNAs in pulmonary fibroblasts. This study utilized...
4.
Ramirez-Hernandez A, Reyes-Jimenez E, Velazquez-Enriquez J, Santos-Alvarez J, Soto-Guzman A, Castro-Sanchez L, et al.
Cells
. 2023 Jul;
12(14).
PMID: 37508515
Idiopathic pulmonary fibrosis (IPF) is the most frequent and severe idiopathic interstitial pneumonia. It is a chronic and progressive disease with a poor prognosis and is a major cause of...
5.
Reyes-Jimenez E, Ramirez-Hernandez A, Santos-Alvarez J, Velazquez-Enriquez J, Gonzalez-Garcia K, Carrasco-Torres G, et al.
Int Immunopharmacol
. 2023 Jul;
122:110664.
PMID: 37481854
Systemic sclerosis (SSc) is an autoimmune disease characterized by microvascular compromise and fibrosis. Pulmonary fibrosis, a prominent pulmonary complication in SSc, results in impaired lung function due to excessive accumulation...
6.
Velazquez-Enriquez J, Ramirez-Hernandez A, Navarro L, Reyes-Avendano I, Gonzalez-Garcia K, Jimenez-Martinez C, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563422
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible lung disorder of unknown cause. This disease is characterized by profibrotic activation of resident pulmonary fibroblasts resulting in aberrant deposition of...
7.
Santos-Alvarez J, Velazquez-Enriquez J, Garcia-Carrillo R, Rodriguez-Beas C, Ramirez-Hernandez A, Reyes-Jimenez E, et al.
Cells
. 2022 Apr;
11(7).
PMID: 35406675
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease. Lesions in the lung epithelium cause alterations in the microenvironment that promote fibroblast accumulation. Extracellular vesicles (EVs) transport proteins, lipids,...
8.
Ramirez-Hernandez A, Velazquez-Enriquez J, Santos-Alvarez J, Lopez-Martinez A, Reyes-Jimenez E, Carrasco-Torres G, et al.
Cells
. 2022 Feb;
11(4).
PMID: 35203281
Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease of unknown etiology. Different types of cells are involved in fibrogenesis, which is persistently physical and molecular stimulation, either directly...
9.
Reyes-Jimenez E, Ramirez-Hernandez A, Santos-Alvarez J, Velazquez-Enriquez J, Pina-Canseco S, Baltierrez-Hoyos R, et al.
Mol Cell Biochem
. 2021 Aug;
476(12):4405-4419.
PMID: 34463938
Pulmonary fibrosis is a chronic progressive disease with high incidence, prevalence, and mortality rates worldwide. It is characterized by excessive accumulation of extracellular matrix in the lung parenchyma. The cellular...
10.
Velazquez-Enriquez J, Santos-Alvarez J, Ramirez-Hernandez A, Reyes-Jimenez E, Lopez-Martinez A, Pina-Canseco S, et al.
Biomedicines
. 2021 Aug;
9(8).
PMID: 34440261
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible, and highly fatal disease. It is characterized by the increased activation of both fibroblast and myofibroblast that results in excessive extracellular...